effects of semaglutide in pregnancy Impact exposure on fetal and neonatal outcomes pregnant women: a systematic review Can the new diabetes and

Description

To view or add a comment, sign in Increased NET levels have also been implicated in insulin resistance and worsening Polycystic Ovary Syndrome (see previous post) Increased levels of NETosis biomarkers in high-grade serous ovarian cancer patients biofluids: Potential role in disease diagnosis and management Thomas Perez et al 2023 Building healthier communities through simple, science-backed habits | Author of The Secret to Good Health and Gita & Health Did you know (Poly Cystic Ovary Syndrome) is largely a metabolic disorder driven by pushing insulin levels up, increasing androgens, and disrupting cycles, ovulation, weight, skin, and mood

Home Medical news & Guidelines Anesthesiology Cardiology and CTVS Critical Care Dentistry Dermatology Diabetes and Endocrinology ENT Gastroenterology Medicine Nephrology Neurology Obstretics-Gynaecology Oncology Ophthalmology Orthopaedics Pediatrics-Neonatology Psychiatry Pulmonology Radiology Surgery Urology Laboratory Medicine Diet Nursing Paramedical Physiotherapy Health news Fact Check Bone Health Fact Check Brain Health Fact Check Cancer Related Fact Check Child Care Fact Check Dental and oral health fact check Diabetes and metabolic health fact check Diet and Nutrition Fact Check Eye and ENT Care Fact Check Fitness fact check Gut health fact check Heart health fact check Kidney health fact check Medical education fact check Men's health fact check Respiratory fact check Skin and hair care fact check Vaccine and Immunization fact check Women's health fact check AYUSH State News Andaman and Nicobar Islands Andhra Pradesh Arunachal Pradesh Assam Bihar Chandigarh Chattisgarh Dadra and Nagar Haveli Daman and Diu Delhi Goa Gujarat Haryana Himachal Pradesh Jammu & Kashmir Jharkhand Karnataka Kerala Ladakh Lakshadweep Madhya Pradesh Maharashtra Manipur Meghalaya Mizoram Nagaland Odisha Puducherry Punjab Rajasthan Sikkim Tamil Nadu Telangana Tripura Uttar Pradesh Uttrakhand West Bengal Medical Education Industry Retatrutide effects greatest Weight Loss in TRIUMPH-4 trial, bests Tirzepatide USA: A first-in-class triple hormone receptor agonist, retatrutide, has demonstrated striking reductions in body weight along with meaningful improvement in knee osteoarthritis symptoms in the first successful Phase 3 trial under the TRIUMPH programme

Case Media A: ECG B: ABIs C: CT Angiogram D: CT Angiogram head and neck E: Pre and post subclavian stentinng F: CT head and neck follow up Episode Schematics & Teaching The CardioNerds 5